Stephen J. Carriere - Jan 19, 2022 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Principal Accounting Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Stephen J. Carriere
Stock symbol
EVLO
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/21/2022, 04:02 PM
Previous filing
Sep 29, 2021
Next filing
Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +6.25K $0.00 6.25K Jan 19, 2022 Common Stock 6.25K $5.05 Direct F1
transaction EVLO Restricted Stock Units Award $0 +1.42K $0.00 1.42K Jan 19, 2022 Common Stock 1.42K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
F2 These RSUs will vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.